CDT Equity gets Nasdaq notice for late quarterly filing

Conduit Pharmaceuticals

Conduit Pharmaceuticals

CDT

0.00
  • CDT Equity received a Nasdaq deficiency notice for failing to file its Form 10-Q for the quarter ended March 31, 2026 on time.
  • The notice cited Nasdaq Listing Rule 5250(c)(1); trading continues with no immediate impact on the listing.
  • Nasdaq set a July 20, 2026 deadline to submit a compliance plan; management expects to file the 10-Q once its review is finished.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.